IMA | NASDAQ

Imagenebio, Inc.

Imagenebio, Inc. (IMA) | runway 45.0 months | financing risk moderate | market cap $64.3M. Daily snapshot of financials, capital pressure, and recent develop...

Company websiteLast updated Apr 29, 2026

Share price

$5.93

As of Apr 29, 2026

Market cap

$64.3M

Snapshot valuation

30D volume

691,091 shares

Rolling average daily volume

Runway

45.0 months

Estimated from precomputed burn and cash

Financing risk

N/A

Financing risk is present, but the current picture is not yet acute.

Snapshot summary

Runway: 45.0 months based on estimated burn.

Recent financing detected on Apr 12, 2026.

Financing signal: Financing risk is present, but the current picture is not yet acute.

Recent developments

ImageneBio, Inc. 8-K 2026-04-13

8-K filed on 2026-04-13.

Apr 12, 2026, 8:00 PM

ImageneBio, Inc. 424B3 2026-04-13

424B3 filing submitted on 2026-04-13.

Apr 12, 2026, 8:00 PM

ImageneBio, Inc. 8-K 2026-03-17

8-K filed on 2026-03-17.

Mar 16, 2026, 8:00 PM

ImageneBio, Inc. 8-K 2026-03-10

8-K filed on 2026-03-10.

Mar 9, 2026, 8:00 PM

ImageneBio, Inc. 10-K 2026-03-10

10-K filed on 2026-03-10.

Mar 9, 2026, 8:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures